Embolization for pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia: A decision analysis

Chest

Volumn 136, Issue 3, 2009, Pages 849-858

  Gupta, Samir ^a,c,e,f   Faughnan, Marie E ^a,c,e   Bayoumi, Ahmed M ^a,b,c,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f Bond Wing   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERY; ARTICLE; ARTIFICIAL EMBOLISM; BRAIN ABSCESS; CASE REPORT; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; DISEASE COURSE; HEMATOTHORAX; HEMOPTYSIS; HUMAN; LIFE EXPECTANCY; MALE; MEDICAL DECISION MAKING; PARAMETER; PRIORITY JOURNAL; PULMONARY ARTERIOVENOUS FISTULA; QUALITY OF LIFE; RENDU OSLER WEBER DISEASE; REPERFUSION; STANDARD; SURVIVAL TIME; TRANSIENT ISCHEMIC ATTACK; TREATMENT FAILURE;

EID: 70049105152     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.09-0334     Document Type: Article

References (67)

1. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995; 333:918-924
2. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91:66-67 (Pubitemid 30127562)
3. Gossage JR, Kanj G. Pulmonary arteriovenous malformations: a state of the art review. Am J Respir Crit Care Med 1998; 158:643-661 (Pubitemid 28378198)
4. Moussouttas M, Fayad P, Rosenblatt M, et al. Pulmonary arteriovenous malformations: cerebral ischemia and neurologic manifestations. Neurology 2000; 55:959-964 (Pubitemid 30764357)
5. White RJ, Lynch-Nyhan A, Terry P, et al. Pulmonary arteriovenous malformations: techniques and long-term outcome of embolotherapy. Radiology 1988; 169:663-669 (Pubitemid 18272756)
6. White RI Jr. Pulmonary arteriovenous malformations: how do we diagnose them and why is it important to do so? Radiology 1992; 182:633-635
7. Lee DW, White RI Jr, Egglin TK, et al. Embolotherapy of large pulmonary arteriovenous malformations: long-term results. Ann Thorac Surg 1997; 64:930-939
8. White RI Jr, Pollak JS, Wirth JA. Pulmonary arteriovenous malformations: diagnosis and transcatheter embolotherapy. J Vasc Interv Radiol 1996; 7:787-804 (Pubitemid 126729603)
9. Burke CM, Safai C, Nelson DP, et al. Pulmonary arteriovenous malformations: a critical update. Am Rev Respir Dis 1986; 134:334-339 (Pubitemid 16046920)
10. Mager JJ, Overtoom TT, Blauw H, et al. Embolotherapy of pulmonary arteriovenous malformations: long-term results in 112 patients. J Vasc Interv Radiol 2004; 15:451-456 (Pubitemid 38590868)
11. Remy-Jardin M, Wattinne L, Remy J. Transcatheter occlusion of pulmonary arterial circulation and collateral supply: failures, incidents, and complications. Radiology 1991; 180: 699-705
12. Milic A, Chan RP, Cohen JH, et al. Reperfusion of pulmonary arteriovenous malformations after embolotherapy. J Vasc Interv Radiol 2005; 16:1675-1683 (Pubitemid 44431165)
13. Puskas JD, Allen MS, Moncure AC, et al. Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg 1993; 56:253-257
14. HHT Foundation International. Hereditary hemorrhagic telangiectasia: physician education. Available at: www.hht. org/hht-foundation/physician- education/. Accessed August 6, 2009
15. Arias E. United States life tables, 2004: national vital statistics reports. Hyattsville, MD: National Center for Health Statistics, 2007
16. Pollak JS, Saluja S, Thabet A, et al. Clinical and anatomic outcomes after embolotherapy of pulmonary arteriovenous malformations. J Vasc Interv Radiol 2006; 17:35-44 (Pubitemid 44392031)
17. Shovlin CL, Jackson JE, Bamford KB, et al. Primary determinants of ischaemic stroke/brain abscess risks are independent of severity of pulmonary arteriovenous malformations in hereditary haemorrhagic telangiectasia. Thorax 2008; 63:259-266
18. Torrance GW. Utility approach to measuring health-related quality of life. J Chronic Dis 1987; 40:593-603
19. Froberg DG, Kane RL. Methodology for measuring health-state preferences: II. Scaling methods. J Clin Epidemiol 1989; 42:459-471 (Pubitemid 19165912)
20. Naimark D, Naglie G, Detsky AS. The meaning of life expectancy: what is a clinically significant gain? J Gen Intern Med 1994; 9:702-707
21. Wright JC, Weinstein MC. Gains in life expectancy from medical interventions: standardizing data on outcomes. N Engl J Med 1998; 339:380-386
22. Hewes RC, Auster M, White RI Jr. Cerebral embolism: first manifestation of pulmonary arteriovenous malformation in patients with hereditary hemorrhagic telangiectasia. Cardiovasc Intervent Radiol 1985; 8:151-155 (Pubitemid 16206071)
23. Remy J, Remy-Jardin M, Giraud F, et al. Angioarchitecture of pulmonary arteriovenous malformations: clinical utility of three-dimensional helical CT. Radiology 1994; 191:657-664 (Pubitemid 24177881)
24. White RI Jr, Pollak JS. Pulmonary arteriovenous malformations: diagnosis with three-dimensional helical CT; a break-through without contrast media. Radiology 1994; 191:613-614
25. Redelmeier DA, Heller DN. Time preference in medical decision making and cost-effectiveness analysis. Med Decis Making 1993; 13:212-217
26. Allareddy V, Konety BR. Specificity of procedure volume and in-hospital mortality association. Ann Surg 2007; 246:135-139 (Pubitemid 47012218)
27. Hannan EL, Wu C, Walford G, et al. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation 2005; 112:1171-1179
28. The Leapfrog Group. The Leapfrog Group. Available at: www.leapfroggroup.org/home. Accessed August 6, 2009
29. White RI Jr, Mitchell SE, Barth KH, et al. Angioarchitecture of pulmonary arteriovenous malformations: an important consideration before embolotherapy. AJR Am J Roentgenol 1983; 140:681-686
30. White RI Jr. Embolotherapy in vascular disease. AJR Am J Roentgenol 1984; 142:27-30
31. Prasad V, Chan RP, Faughnan ME. Embolotherapy of pulmonary arteriovenous malformations: efficacy of platinum versus stainless steel coils. J Vasc Interv Radiol 2004; 15:153-160 (Pubitemid 38248915)
32. Gupta P, Mordin C, Curtis J, et al. Pulmonary arteriovenous malformations: effect of embolization on right-to-left shunt, hypoxemia, and exercise tolerance in 66 patients. AJR Am J Roentgenol 2002; 179:347-355 (Pubitemid 34785635)
33. Caro JJ, Huybrechts KF. Stroke treatment economic model (STEM): predicting long-term costs from functional status. Stroke 1999; 30:2574-2579
34. National Aeronautics and Space Administration. Gross domestic product deflator inflation calculator. Available at: http://cost.jsc.nasa.gov/ inflateGDP.html. Accessed August 6, 2009
35. Swanson KL, Prakash UB, Stanson AW. Pulmonary arteriovenous fistulas: Mayo Clinic experience, 1982-1997. Mayo Clin Proc 1999; 74:671-680
36. Gomes MR, Bernatz PE, Dines DE. Pulmonary arteriovenous fistulas. Ann Thorac Surg 1969; 7:582-593
37. Cottin V, Chinet T, Lavole A, et al. Pulmonary arteriovenous malformations in hereditary hemorrhagic telangiectasia: a series of 126 patients. Medicine 2007; 86:1-17 (Pubitemid 46104915)
38. Maher CO, Piepgras DG, Brown RD Jr, et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. Stroke 2001; 32:877-882
39. Post MC, Letteboer TG, Mager JJ, et al. A pulmonary right-to-left shunt in patients with hereditary hemorrhagic telangiectasia is associated with an increased prevalence of migraine. Chest 2005; 128:2485-2489
40. Gallitelli M, Guastamacchia E, Resta F, et al. Pulmonary arteriovenous malformations, hereditary hemorrhagic telangiectasia, and brain abscess. Respiration 2006; 73:553-557 (Pubitemid 43909762)
41. Dutton JA, Jackson JE, Hughes JM, et al. Pulmonary arteriovenous malformations: results of treatment with coil embolization in 53 patients. AJR Am J Roentgenol 1995; 165:1119-1125
42. Haitjema TJ, Overtoom TT, Westermann CJ, et al. Embolisation of pulmonary arteriovenous malformations: results and follow up in 32 patients. Thorax 1995; 50:719-723
43. Sluiter-Eringa H, Orie NG, Sluiter HJ. Pulmonary arteriovenous fistula: diagnosis and prognosis in noncompliant patients. Am Rev Respir Dis 1969; 100:177-188
44. Pick A, Deschamps C, Stanson AW. Pulmonary arteriovenous fistula: presentation, diagnosis, and treatment. World J Surg 1999; 23:1118-1122 (Pubitemid 29480701)
45. Vase P, Holm M, Arendrup H. Pulmonary arteriovenous fistulas in hereditary hemorrhagic telangiectasia. Acta Med Scand 1985; 218:105-109 (Pubitemid 15250328)
46. Sagara K, Miyazono N, Inoue H, et al. Recanalization after coil embolotherapy of pulmonary arteriovenous malformations: study of long-term outcome and mechanism for recanalization. AJR Am J Roentgenol 1998; 170:727-730 (Pubitemid 28106672)
47. Remy J, Remy-Jardin M, Wattinne L, et al. Pulmonary arteriovenous malformations: evaluation with CT of the chest before and after treatment. Radiology 1992; 182:809-816
48. Appelros P, Nydevik I, Viitanen M. Poor outcome after first-ever stroke: predictors for death, dependency, and recurrent stroke within the first year. Stroke 2003; 34:122-126 (Pubitemid 36070812)
49. Tseng JH, Tseng MY. Brain abscess in 142 patients: factors influencing outcome and mortality. Surg Neurol 2006; 65: 557-562 (Pubitemid 43729607)
50. Sell B, Evans J, Horn D. Brain abscess and hereditary hemorrhagic telangiectasia. South Med J 2008; 101:618-625
51. Hakan T, Ceran N, Erdem I, et al. Bacterial brain abscesses: an evaluation of 96 cases. J Infect 2006; 52:359-366
52. Britton M, Gustafsson C. Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985; 16:182-188 (Pubitemid 15144719)
53. Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke 2001; 32:392-398 (Pubitemid 32155224)
54. Di Carlo A, Lamassa M, Baldereschi M, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003; 34:1114-1119 (Pubitemid 36547498)
55. Jorgensen HS, Nakayama H, Reith J, et al. Acute stroke with atrial fibrillation: the Copenhagen Stroke Study. Stroke 1996; 27:1765-1769 (Pubitemid 26332501)
56. Dakurah TK, Iddrissu M, Wepeba G, et al. Hemispheric brain abscess: a review of 46 cases. West Afr J Med 2006; 25:126-129 (Pubitemid 44209653)
57. Prasad KN, Mishra AM, Gupta D, et al. Analysis of microbial etiology and mortality in patients with brain abscess. J Infect 2006; 53:221-227 (Pubitemid 44391066)
58. Knottenbelt JD, Van der Spuy JW. Traumatic haemothorax: experience of a protocol for rapid turnover in 1,845 cases. S Afr J Surg 1994; 32:5-8
59. Knott-Craig CJ, Oostuizen JG, Rossouw G, et al. Management and prognosis of massive hemoptysis: recent experience with 120 patients. J Thorac Cardiovasc Surg 1993; 105:394-397 (Pubitemid 23097618)
60. Reechaipichitkul W, Latong S. Etiology and treatment outcomes of massive hemoptysis. Southeast Asian J Trop Med Public Health 2005; 36:474-480 (Pubitemid 40825554)
61. Ong TH, Eng P. Massive hemoptysis requiring intensive care. Intensive Care Med 2003; 29:317-320 (Pubitemid 36384424)
62. Stebbings AE, Lim TK. Cause, treatment and outcome of patients with life-threatening haemoptysis. Singapore Med J 1999; 40:67-69
63. Grosso M, Groppo Marchisio F, Testa F, et al. Pulmonary arteriovenous malformations: percutaneous treatment preserving parenchyma in high-flow fistulae. Radiol Med 2008; 113:395-413 (Pubitemid 351725522)
64. Hartnell GG, Jackson JE, Allison DJ. Coil embolization of pulmonary arteriovenous malformations. Cardiovasc Intervent Radiol 1990; 13:347-350
65. Messori A, Trippoli S, Becagli P, et al. Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost-utility analysis. Eur J Clin Pharmacol 1998; 53:421-427 (Pubitemid 28154742)
66. Tufts Medical Center Institute for Clinical Research and Health Policy Studies. CEA registry: Center for the Evaluation of Value and Risk in Health. Available at: https:// research.tufts-nemc.org/cear/. Accessed August 6, 2009
67. Naglie G, Krahn MD, Naimark D, et al. Primer on medical decision analysis: III. Estimating probabilities and utilities. Med Decis Making 1997; 17:136-141